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Objective: Evidence suggests that social skills training 
(SST) is an efficacious intervention for negative symp-
toms in psychosis, whereas evidence of efficacy in other 
psychosis symptom domains is limited. The current article 
reports a comprehensive meta-analytic review of the evi-
dence for SST across relevant outcome measures, control 
comparisons, and follow-up assessments. The secondary 
aim of this study was to identify and investigate the effi-
cacy of SST subtypes. Methods: A systematic literature 
search identified 27 randomized controlled trials includ-
ing N = 1 437 participants. Trials assessing SST against 
active controls, treatment-as-usual (TAU), and wait-
ing list control were included. Risk of bias was assessed 
using the Cochrane risk of bias assessment tool. A series 
of 70 meta-analytic comparisons provided effect sizes 
in Hedges’ g. Heterogeneity and publication bias were 
assessed. Results: SST demonstrated superiority over 
TAU (g  =  0.3), active controls (g  =  0.2–0.3), and com-
parators pooled (g = 0.2–0.3) for negative symptoms, and 
over TAU (g = 0.4) and comparators pooled (g = 0.3) for 
general psychopathology. Superiority was indicated in a 
proportion of comparisons for all symptoms pooled and 
social outcome measures. SST subtype comparisons were 
underpowered, although social-cognitive approaches dem-
onstrated superiority vs comparators pooled. SST treat-
ment effects were maintained at proportion of follow-up 
comparisons. Conclusions: SST demonstrates a magnitude 
of effect for negative symptoms similar to those commonly 
reported for cognitive-behavioral therapy (CBT) for posi-
tive symptoms, although unlike CBT, SST is not routinely 
recommended in treatment guidelines for psychological 
intervention. SST may have potential for wider implemen-
tation. Further stringent effectiveness research alongside 
wider pilot implementation of SST in community mental 
health teams is warranted.
Key words:  social skills training/psychosis/ 
schizophrenia/meta-analysis
Introduction
Social skills training (SST) is a psychological intervention 
focused upon the development or improvement of social 
interaction, social performance, or interpersonal skills, 
primarily offered to patients diagnosed with schizophre-
nia-spectrum disorders or psychosis. SST was initially 
developed in the context of the deinstitutionalization of 
psychiatric patients returning to the community in the 
1970s and utilized behavioral techniques such as role-
play, modeling, coaching, instruction, and feedback in an 
attempt to address interpersonal deficits. The literature 
from this period described SST as an effective means of 
reducing social anxiety, although suggested that improved 
generalizability to real-life situations was desirable.1
Since an initial wave of development in the 1980s and 
1990s, SST has diversified meaning that a range of related 
interventions may now be subsumed within the terminol-
ogy. The term SST, therefore, represents a broader spec-
trum of related interventions within the contemporary 
literature. These include approaches focused primarily 
on social cognition that may also integrate technology. 
Such approaches differ from the similar cognitive reme-
diation methodology by their focus primarily upon social 
cognitive process and social perception rather than upon 
improving neuropsychological variables such as memory, 
attention, or executive function.2,3 Similarly, a number 
of SST approaches assimilate cognitive-behavioral tech-
niques such as cognitive restructuring, although they 
follow an SST-style group format as opposed to the typi-
cal formulation-based approach of cognitive-behavioral 
therapy (CBT).4 Finally, a number of practically focused 
approaches integrating SST with psycho-education, life 
management skills, and relapse prevention strategies also 
exist.5,6
Negative symptoms refer to a specific pattern of com-
monly observed deficits in psychosis such as passive or 
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blunting of affect, and rigid or stereotypical thinking.7 
Comparatively less research has focused upon the treat-
ment of negative symptoms than positive symptoms while 
fewer targeted interventions have been developed. Only 
in recent years have negative symptoms been included as 
primary outcomes in SST-based interventions since early 
studies focused on social functioning outcomes.1Fusar-
Poli et al8 assessed the efficacy of pharmacological and 
psychological interventions for negative symptoms in a 
large meta-analysis and reported a medium effect size for 
second-generation antipsychotics vs placebo (g = 0.6, P 
≤ .05), whereas their comparison of 10 randomised con-
trolled trial (RCTs) for first-generation antipsychotics 
vs placebo was not significant (g = 0.05, P = .69). Both 
comparisons displayed a high degree of heterogeneity, 
whereas for psychological interventions pooled, they 
reported a small-to-medium effect size (g = 0.4, P ≤ .05) 
and moderate heterogeneity. The effect size for antide-
pressants was smaller (g = 0.3, P ≤ .05). The question of 
whether medication is more efficacious than psychologi-
cal interventions pooled is not straightforward because 
the majority of participants in RCTs for psychological 
interventions are already maintained on antipsychotic 
medication which has impact upon target symptoms. 
However, this meta-analytic evidence suggests that dif-
ferences in efficacy between psychological and pharma-
cological interventions for negative symptoms are small.8
A recent meta-analysis reported similar small-to-
medium effect sizes (g = 0.3–0.6) in favor of SST when 
compared to other psychological interventions for nega-
tive symptoms in psychosis.9 Interestingly, the magnitude 
of the effect size increased with progressive sensitivity 
analyses to address risk of bias suggesting robustness. The 
UK National Institute for Health and Care Excellence 
(NICE) guidelines state that SST should not be offered 
as a specific intervention for psychosis following their 
conclusion in 2009 that SST did not show sufficient supe-
riority over standard care alongside concerns regarding 
limited generalizability to everyday living,10 whereas in the 
United States, guidelines have suggested that SST is not 
an effective means to reduce symptoms.11 SST is not rou-
tinely integrated within adult clinical psychology or com-
munity mental health settings in the UK National Health 
Service (NHS). CBT is the most widely recommended 
and integrated psychological intervention for psychosis 
in the UK, although many CBT manuals focus primarily 
on addressing positive rather than negative symptoms of 
psychosis.12 Earlier meta-analytic evidence suggested that 
CBT may be effective for negative symptoms (g = 0.4, 
P < .05).13 This effect was not, however, maintained when 
the authors excluded nonrandomized studies and could 
not be replicated in a more recent meta-analysis when 
negative symptoms were primary (g = 0.2, P > .05) or 
secondary (g = 0.1, P > .05) outcomes.14 The consider-
ation that SST appears relatively more efficacious than 
CBT in reducing negative symptoms and has produced 
effect sizes comparable to pharmacological treatments 
suggests that further examination of its clinical utility is 
warranted.
The current review aimed to expand upon the prom-
ising meta-analytic evidence for SST from our previous 
comparative meta-analysis of psychological interventions 
for psychosis by applying a more comprehensive focus on 
SST and including all comparison conditions rather than 
only bona fide psychological interventions. To the best of 
our knowledge, it is 8 years since SST has been thoroughly 
examined via meta-analysis.15 Given the accumulation of 
articles since this time means that a renewed evaluation 
of its effectiveness is warranted. Because SST has further 
diversified into a range of related interventions, we aimed 
to define and assess subtypes of SST as an adjunct to our 
primary comparisons. We also aimed to account for vary-
ing methodological rigor among SST trials because previ-
ous reviews did not address risk of bias within RCTs.16,17 
Our overall aim was therefore to provide a detailed meta-
analytic review of the contemporary evidence-base for 
SST, with robust appraisal of risk of bias and method-
ological quality in RCTs. Our primary objective was to 
determine whether SST and SST subtypes demonstrate 
superiority in reducing negative symptoms against rel-
evant comparison conditions. We hypothesized that SST 
would demonstrate superiority for negative symptoms 
across comparisons, whereas superiority would not be 
demonstrated in other symptom domains.
Methods
A systematic literature search and meta-analysis was per-
formed following PRISMA guidelines for the reporting 
of systematic reviews and meta-analyses.18
Protocol
The objectives and intended methodology of this proj-
ect were registered via PROSPERO on May 9, 2016 




A systematic literature search was completed in May 
2016 (with no limits applied for year of publication) and 
included four databases: The Cochrane Central Register 
of Controlled Trials, Pubmed, PsychInfo, and Embase. 
Abstracts were identified by entering text variations of 
three key terms dependent upon Boolean operators, 
MeSH terms, exploded terms, and limit settings relevant 
to each database, namely, (1) social skills training and 
related interventions, (2) psychosis and related diagno-
ses, and (3) randomized controlled trials. Further search 
strings have been included in Supplementary Material. 
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considered for inclusion.9,16,17,19,20 Trial registrations, con-
ference abstracts, and dissertations were also considered 
via grey literature checks online.
Study Selection
Studies were included if  they were randomized controlled 
trials in which social skills training or related interven-
tions were compared against a control condition and 
applied to a psychosis population. Studies also met the 
following inclusion criteria: (a) the participants were 
diagnosed with psychotic disorders including schizophre-
nia, schizoaffective disorder, delusional disorder, brief  
psychotic disorder, or psychosis not otherwise specified 
(NOS); (b) the intervention was defined as SST or was 
primarily intended to improve social performance; (c) the 
study was fully randomized and included comparison to 
an active control, treatment-as-usual (TAU), or a waiting 
list control; and (d) relevant outcome measures assess-
ing psychotic symptoms and/or social performance were 
reported at post-treatment and/or follow-up. Active con-
trols include comparison of SST against other bona fide 
interventions such as cognitive-behavioral therapy and 
therefore provide the most stringent comparison.
Studies were excluded if  (a) participants had alterna-
tive or comorbid diagnoses, such as substance abuse or 
ultra-high risk of psychosis; (b) missing data could not 
be obtained by contacting authors; or (c) authors mixed 
elements of SST and other interventions into the inter-
vention and/or control condition resulting in difficulty 
comparing the active SST element (eg, SST plus oxyto-
cin). Only studies reported in the English language were 
included.
Risk of Bias Assessment
For consistency with the previous meta-analysis,9 RCTs 
were assessed at the study level against the first four cri-
teria of the Cochrane risk of bias tool: sequence gener-
ation, allocation concealment, blinding of assessors, and 
incomplete outcome data. The final two items (selec-
tive outcome reporting and other sources of bias) were 
omitted because there is no evidence of their impact 
upon validity in meta-analysis.21 The third item (blind-
ing of assessors) was adapted to include only outcome 
assessors in blinding because, unlike medication trials, 
study therapists and participants cannot be blinded to 
the intervention being delivered. Two authors (D.T. and 
E.M.G.) calculated risk of bias scores via independent 
rating and resolution by discussion for 13 (48%) of the 
included studies, whereas risk of bias assessments for 14 
(52%) studies were utilized from the previously published 
meta-analysis.9 Risk of bias items were rated as high-risk 
or low-risk, whereas unclear items were categorized as 
high-risk.
Data Extraction
Symptom-related outcome data were extracted from 14 
studies as part of the previous publication.9 These data 
were checked for consistency and included in the current 
analysis. One author (D.T.) extracted symptom-related 
outcome data from the remaining 13 studies and extracted 
social performance outcome data for all studies, whereas 
another (E.M.G.) checked consistency. Spreadsheets 
piloted and utilized in the previous meta-analysis were 
employed for extraction. We contacted five authors22–25 
with requests for missing or unpublished outcome data, 
resulting in one successful further inclusion.26
Outcome Measures
All continuous outcome measures relevant to psychotic 
symptoms, general psychopathology, and social perfor-
mance were extracted. We considered negative symptoms 
the primary outcome measure based on results of the 
previous meta-analysis.9 In instances where multiple out-
come measures were reported within one domain, all data 
were extracted and combined to form a pooled effect size 
for that domain. In a minority of studies, only dichoto-
mous outcome data were available. These were converted 
into Hedges’ g according to the methods integrated in 
Comprehensive Meta-Analysis (CMA).27 The all symp-
toms comparison therefore includes relapse, discharge, 
and clinical exacerbation as proxy symptom measures.
Meta-Analyses
The overall strategy for the meta-analyses was to prog-
ress gradually from a broad and inclusive sample of stud-
ies toward more methodologically robust comparisons. 
This meant that for each outcome measure category (all 
symptoms, positive symptoms, negative symptoms, gen-
eral symptoms, and social performance) or comparison 
category (all comparators, active controls, TAU, and sup-
portive counseling [SC] only), separate meta-analyses 
were performed for progressively decreasing risk of bias 
(0–4, where 4 indicates the highest risk of bias) when pos-
sible based on study availability. Meta-analyses were per-
formed on outcome measures or comparator categories 
when at least five studies were available. Risk of bias sen-
sitivity analyses were performed when at least four stud-
ies were available. It was acknowledged that comparisons 
meeting the minimum required number of studies would 
be considerably underpowered.
In order to investigate differences in efficacy between 
SST variations and related interventions, two authors 
(D.T. and A.M.) identified subtypes of SST independently 
and resolved disagreements by discussion before final cat-
egorization. Separate meta-analyses were then performed 
using the same procedures as above. Similarly, meta-anal-
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conducted when there were at least four studies available 
at any given follow-up time point (eg, 6 months).
For meta-analyses which did not require the combina-
tion of outcome measures at study level, the computer 
software R Studio version 1.0.136 was used to calculate 
pooled effect sizes using the packages meta and meta-
for.28,29 For comparisons that included studies where two 
outcome measures were reported in the same domain (eg, 
two measures of negative symptoms), Comprehensive 
Meta-Analysis, version 3.0 was used due to its ability 
to provide a combined effect size at the study level. The 
programs were checked for consistency of results on a 
proportion of comparisons. Both software packages 
provided an aggregated effect size indicating the pooled 
mean difference between groups at post-treatment or fol-
low-up using Hedges’ g. Hedges’ g is an estimate of the 
standardized mean difference between groups and pro-
vides a more accurate estimate of effects in small samples 
than similar statistics for continuous outcome variables 
such as Cohen’s d.30 Alpha was set to 0.05 for all compari-
sons and 95% confidence intervals were obtained.
Heterogeneity
Both software packages calculated chi-square tests to 
assess the degree of heterogeneity for each comparison. 
The Q statistic and resultant alpha level were used to 
determine the presence of heterogeneity in each compari-
son. The I2 statistic described the percentage of variance 
in each comparison that may arise from heterogeneity 
between studies or outcome measures rather than by 
chance. For the purpose of assessment, heterogeneity was 
defined as absent (0%), low (25%), moderate (50%), and 
high (75%).31 A 95% confidence interval was calculated 
for the I2 statistic.
Publication Bias
Publication bias for all meta-analyses was established 
by examining funnel plots.32 Duval and Tweedie’s33 trim 
and fill procedure was used to estimate effect sizes after 
accounting for publication bias, whereas Egger’s34 test 
of the intercept was applied to quantify bias and assess 
significance.
Power Analysis
Due to progressive sensitivity analyses and our identifi-
cation of SST subtypes, a number of comparisons were 
likely to be underpowered. We therefore utilized power 
analysis to determine the approximate number of studies 
required to identify relevant effects. Previous meta-analy-
sis identified effect sizes ranging from roughly g = 0.2–0.6 
for SST.9 Based on Cuijpers’35 table, for an average N of  
30 per group in each study and conservatively assuming 
0.80 power alongside alpha level 0.05, it was estimated 
that 18 studies would be required to detect an effect size 
of g = 0.2 for comparisons with low between study vari-
ances. Comparisons with medium and high variances 
would require 22 and 26 studies, respectively.
Results
Study Selection
Figure 1 illustrates the selection process by which articles 
were screened for inclusion. Following removal of dupli-
cates, 1 972 title abstracts were screened for relevant char-
acteristics; a further 176 articles were retrieved for closer 
inspection of inclusion and exclusion criteria. Twenty-
seven randomized controlled trials qualified for final 
inclusion resulting in data for N = 1 437 participants being 
included across 70 meta-analyses and sensitivity analyses. 
All included RCTs reported outcome measures at post-
treatment, whereas 11 studies (40%) included follow-up 
data ranging from 12 weeks to 18 months post-treatment.
Selected characteristics of included studies are avail-
able in Table 1. Twenty-five studies (93%) applied group 
format, whereas only two applied individual format. Risk 
of bias scores within studies ranged from 1 to 4.  This 
meant that no studies achieved the lowest possible risk 
of bias score, and therefore, sensitivity analyses could not 
exclude all risk of bias. Details of risk of bias assessments 
at the study level are included in Supplementary Material. 
Four broad subtypes of SST were identified as defined in 
Table 2 and formed the basis of subtype comparisons.
Effect of SST on Psychosis Symptoms
Results for all comparisons of SST against active con-
trols, TAU, SC, and all comparators pooled are provided 
in Table 3. A summary forest plot of significant compari-
sons is provided in Figure 2. Separate meta-analyses were 
calculated for each symptom category and followed by 
risk of bias sensitivity analyses. SST was more efficacious 
than TAU for all symptoms (g = 0.28, P = .02) but did 
not demonstrate superiority against comparators pooled, 
active controls, or SC. The effect vs TAU was robust when 
removing studies with risk of bias scores of ≥4 (where 4 
indicates the highest risk of bias score), although further 
sensitivity analyses were not possible due to limited study 
availability and the significant ≥4 comparison was under-
powered. Heterogeneity was absent in the TAU compari-
son, although other nonsignificant comparisons for all 
symptoms pooled showed moderate-to-high heterogene-
ity. SST did not demonstrate superiority in any compari-
son for positive symptoms while heterogeneity was also 
moderate to high in this domain.
SST was more efficacious for negative symptoms when 
compared to all comparators pooled, active controls, and 
TAU. SST was more efficacious compared to pooled com-
parators (g = 0.19, P = .01) when all eligible studies were 
included in the analysis. When progressive removal of bias 
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to g = 0.28 (P = .01). A similar trend was observed for 
comparison to active controls, where initial comparisons 
including all studies approached significance while grad-
ual removal of bias resulted in an effect size of g = 0.28 
(P = .01). In comparison to TAU, SST was more effica-
cious when all studies were included (g = 0.31, P = .01), 
although studies only allowed for removal of studies with 
a bias risk score of ≥4 (g = 0.30, P =  .02). The ≥4 bias 
comparison was underpowered. SST did not demonstrate 
superiority against SC for negative symptoms, but this 
comparison was underpowered with only four studies 
available. There was no evidence of heterogeneity among 
negative symptom comparisons.
For Positive and Negative Syndrome Scale (PANSS) 
general symptoms, SST demonstrated superiority 
against comparators pooled (g = 0.32, P = .02) and TAU 
(g  =  0.40, P  =  .01). The limited number of available 
studies in this symptom domain meant that sensitivity 
analyses for risk of bias were not possible while compari-
sons were underpowered. There was no evidence of sig-
nificant heterogeneity.
Effect of SST for Social Performance
The results for social performance outcome measures are 
displayed in Table 3. SST was more efficacious when com-
pared to all comparators pooled. This effect size gradually 
increased from g = 0.33(P = .01) when all eligible studies 
were included to g = 0.37 (P < .03) when studies scoring 
≥3 on bias risk were excluded. The treatment effect was 
no longer significant on the final sensitivity analysis for 
studies scoring ≥2 on bias risk, although this comparison 
was underpowered with only five studies available. SST 
did not demonstrate significant superiority against active 
controls or TAU, although the TAU comparison was par-
ticularly underpowered. The majority of comparisons in 
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Scale for Assessment of Negative Symptoms; SBS, Social Behavior Schedule; SBST, Social Behavior Sequencing Task; SC, Supportive 
Counseling; SDSS, Social Disability Screening Schedule; SFS, Social Functioning Scale; SSPA, SSIT, Simulated Social Interaction Test; 
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Table 2. Social Skills Training (SST) Subtype Descriptions and Comparison Types
Definition Nst Np
1.  Cognitive-behavioral social skills training (CBSST): CBSST defined interventions which utilized primarily 
a social-skills training approach similar to generic SST but also integrated cognitive-behavioral techniques 
such as cognitive restructuring, thought challenging or behavioral experiments. To limit heterogeneity, 
we attempted to exclude interventions that were primarily structured as formulation-based CBT-based 
approaches that added aspects of SST because these interventions have less explicit skills training focus.4,26
44,26,43,45 243
2.  Generic social skills training: Generic SST refers to approaches that remain close to the original model of 
SST emerging in the 1980s. Typically this consists of a behaviorally oriented, group intervention based 
upon social learning traditions in which the therapist(s) engage participants in interpersonal training 
sessions. The focus is typically upon assertiveness, verbal and non-verbal communication, reduction of 
social distress, and learning appropriate contextual responses in social situations. This may be achieved via 
modeling, role-play, rehearsal, group reflection and discussion, or a variety of related methods.1,48
740,42,46,47,52,57,59 287
3.  Social-cognitive skills training (SCST): This category refers to a relatively broad range of interventions 
that focus primarily on refining social cognitive processes such as emotion perception, theory-of-mind 
abilities. In order to qualify, interventions were required to include a therapist-led, behavioral, or reflective 
element in order to demonstrate distinction from approaches further on a continuum toward cognitive 
remediation. SCST may integrate computer programs or videos in order to facilitate improved training of 
social responses and may also follow a “drill and repeat” structure.49,50
82,3,25,37,38,41,49,60 295
4.  UCLA-FAST based: The acronym for this category refers firstly to those interventions explicitly based 
upon the University of California Los Angeles (UCLA) model of skills training, which integrates 
traditional SST alongside aspects of psycho-education, relapse prevention, and skills in managing daily 
life tasks such as medication or independent travel. A similar approach is functional adaptive skills 
training (FAST); therefore, these varieties of SST were combined to form a more practical-skills based 
category.5,6,51
85,6,24,39,50,52,55,58 612
5.  Treatment-as-usual (TAU) comparison: Refers to standard clinical care received by patients. TAU cannot 
be considered an active control in meta-analysis because intervention is nonstandardized, whereas both 
intervention and control groups in psychosis are likely to receive some form of TAU (eg, medication).
6.  Active controls: Includes bona-fide interventions such as cognitive-behavioral therapy alongside less 
recognized but standardized control interventions such as supportive counseling
7.  Supportive counseling (SC): Refers to nondirective supportive therapeutic contact which includes key 
common ingredients of therapy such as empathy and rapport without specific techniques of therapy 
models.39
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Table 3. Effect Sizes of SST Across Outcome Measures and Comparison Conditions
N G 95% CI Z P of  Z Q-value I2 (%) I2 95% CI
SST for all symptom measures pooled
 Vs any comparator
  All eligible studies 25 0.097 −0.074, 0.267 1.112 .266 53.99* 55.48 30–72
   Excluding risk of bias score 
of 4
21 0.090 −0.091, 0.270 0.973 .331 46.13* 56.64 29–73
  Excluding risk of bias score ≥3 13 0.106 −0.131, 0.343 0.879 .379 34.59* 65.30 37–81
  Excluding risk of bias score ≥2 7 0.173** −0.026, 0.373 1.704 .088 6.42 6.49 0–73
 Vs active controls
  All eligible studies 18 0.067 −0.151, 0.286 0.605 .545 45.23* 62.42 37–77
   Excluding risk of bias score 
of 4
15 0.051 −0.118, 0.281 0.440 .660 37.30* 62.47 34–79
  Excluding risk of bias score ≥3 10 0.088 −0.209, 0.385 0.581 .561 32.38* 72.20 47–85
  Excluding risk of bias score ≥2 6 0.165 −0.061, 0.392 1.431 .152 6.19 19.15 0–64
 Vs TAU
  All eligible studies 6 0.282* 0.049, 0.515 2.373 .018 2.80 0.00 0–75
   Excluding risk of bias score 
of 4
5 0.300* 0.054, 0.546 2.386 .017 2.61 0.00 0–79
 Vs SC only
  All eligible studies 7 −0.104 −0.456, 0.247 −0.58 .560 18.88* 68.23 30–86
   Excluding risk of bias score 
of 4
6 −0.090 −0.499, 0.318 −0.432 .666 18.81* 73.42 39–88
  Excluding risk of bias score ≥3 4 −0.086 −0.669, 0.488 −0.294 .769 17.99* 83.32 58–93
SST for positive symptoms
 Vs any comparator
  All eligible studies 13 0.0895 −0.117, 0.296 0.85 .397 23.88* 49.8 5–73
   Excluding risk of bias score 
of 4
12 0.984 −0.122, 0.318 0.88 .381 23.72* 53.6 11–76
  Excluding risk of bias score ≥3 9 0.980 −0.150, 0.350 0.78 .438 18.36* 56.4 8–79
  Excluding risk of bias score ≥2 5 0.050 −0.362, 0.460, 0.23 .819 14.70* 72.8 32–89
 Vs active controls
   All eligible studies/ excluding 
risk of bias 4
8 0.080 −0.223, 0.380, 0.50 .620 19.80* 64.6 25–83
  Excluding risk of bias score ≥3 7 0.127 −0.194, 0.450, 0.78 .437 18.04* 66.7 26–85
  Excluding risk of bias score ≥2 5 0.050 −0.362, 0.460, 0.23 .819 14.70* 72.8 32–89
 Vs TAU
  All eligible studies 5 0.151 −0.098, 0.400, 1.19 .235 3.68 0.00 0–79
   Excluding risk of bias score 
of 4
4 0.176 −0.110, 0.460, 1.22 .222 3.31 9.30 0–86
SST for negative symptoms
 Vs any comparator
  All eligible studies 17 0.191* 0.043, 0.338 2.53 .011 19.67 18.65 0–54
   Excluding risk of bias score 
of 4
15 0.218* 0.077, 0.359 3.03 .002 14.66 4.48 0–56
  Excluding risk of bias score ≥3 11 0.194* 0.041, 0.346 2.49 .013 7.96 0.00 0–60
  Excluding risk of bias score ≥2 7 0.279* 0.087, 0.471 2.85 .004 5.07 0.00 0–71
 Vs active controls
  All eligible studies 11 0.136 −0.070, 0.341 1.29 .196 16.01 37.52 0–69
   Excluding risk of bias score 
of 4
10 0.185** −0.009, 0.378 1.87 .061 11.94 24.61 0–64
  Excluding risk of bias score ≥3 8 0.196* 0.010, 0.383 2.07 .039 0.74 9.54 0–68
  Excluding risk of bias score ≥2 6 0.276* 0.073, 0.478 2.67 .008 5.05 1.04 0–75
 Vs TAU
  All eligible studies 6 0.311* 0.078, 0.544 2.61 .009 2.17 0.00 0–75
   Excluding risk of bias score 
of 4
5 0.300* 0.054, 0.546 2.39 .017 2.09 0.00 0–79
 Vs SC only
  All eligible studies 4 0.013 −0.283, 0.257 0.09 .927 2.77 0.00 0–85
SST for PANSS general symptoms
  Vs any comparator, all eligible 
studies
6 0.318* 0.043, 0.594 2.26 .023 7.33 31.70 0–72
 Vs TAU, all eligible studies 4 0.404* 0.111, 0.697 2.70 .007 2.31 0.00 0–85
SST for social competency outcome measures
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  All eligible studies 17 0.326* 0.079, 0.572 2.59 .010 49.60* 67.79 47–81
   Excluding risk of bias score 
of 4
13 0.364* 0.100, 0.628 2.70 .007 37.27* 67.80 43–82
  Excluding risk of bias score ≥3 9 0.372* 0.036, 0.709 2.17 .030 33.20* 75.91 54–87
  Excluding risk of bias score ≥2 5 0.193 −0.065, 0.451 1.47 .143 5.44 26.48 0–72
 Vs active controls
  All eligible studies 12 0.131 0.234, 0496 0.70 .482 59.59* 81.53 69–89
   Excluding risk of bias score 
of 4
10 0.227 −0.170, 0.624 1.12 .262 51.16* 82.41 69–90
  Excluding risk of bias score ≥3 8 0.320 −0.098, 0.738 1.50 .134 39.98 82.49 67–91
  Excluding risk of bias score ≥2 5 0.020 −0.312, 0.353 0.12 .906 8.86 54.88 0–83
 Vs TAU
  All eligible studies 5 0.201 −0.140, 0.541 1.16 .248 5.31 24.69 0–70
SST subtypes vs any comparator
 All symptom measures pooled
   Generic SST, all eligible 
studies
7 0.171 −0.127, 0.468 1.13 .260 8.70 31.77 0–71
   Generic SST, excl. risk of bias 
≥4
4 0.364** −0.011, 0.739 1.90 .057 4.21 28.71 0–74
   Cognitive-behavioral SST, 
excl. risk of bias ≥3
4 0.147 −0.108, 0.403 1.13 .258 0.59 0.00 0–85
   Social-cognitive SST, excl. risk 
of bias ≥4
6 0.270 −0.027, 0.567 1.78 .075 6.40 21.92 0–66
   Social-cognitive SST, excl. risk 
of bias ≥3
5 0.392* 0.107, 0.678 2.70 .007 2.48 0.00 0–79
   Social-cognitive SST, excl. risk 
of bias ≥2
4 0.413* 0.116, 0.709 2.73 .006 2.24 0.00 0–85
   UCLA-FAST, all eligible 
studies
8 −0.058 −0.392, 0.276 −0.34 .733 25.19* 72.21 43–86
  UCLA-FAST, risk of bias ≥4 7 −0.176 −0.461, 0.109 −1.21 .226 15.71* 61.81 13–83
   UCLA-FAST, excl. risk of 
bias ≥3
4 −0.201 −0.649, 0.246 −0.88 .378 14.65 79.52 46–92
 Negative symptoms
   Generic SST, all eligible 
studies
5 0.268 −0.143, 0.678 1.28 .201 8.66 53.83 0–83
   Cognitive-behavioral SST, all 
eligible studies
4 0.146 −0.117, 0.402 1.11 .266 0.46 0.00 0–85
   Social-cognitive SST, all 
eligible studies
5 0.148 −0.213, 0.509 0.80 .421 6.47 38.14 0–77
 Social competency outcome measures
   Generic SST, all eligible 
studies
4 −0.031 −0.318, 0.256 0.21 .832 1.31 0.00 0–85
   Social-cognitive SST, all 
eligible studies
7 0.301 −0.211, 0.812 1.15 .249 23.41* 74.37 45–88
   Social-cognitive SST, excl. risk 
of bias ≥4
6 0.188 −0.340, 0.716 0.70 .485 19.86* 74.82 43–89
   Social-cognitive SST, excl. risk 
of bias ≥3
4 0.478** −0.018, 0.975 1.89 .059 8.38* 64.18 0–88
   UCLA-FAST, all eligible 
studies
5 0.080 −0.587, 0.747 0.24 .814 36.19* 88.95 77–95
   UCLA-FAST, excl. risk of 
bias ≥4
4 0.267 −0.432, 0.966 0.75 .454 27.9* 89.25 75–95
SST vs any comparator at 6 mo follow-up
 All symptoms, all eligible studies 8 0.035 −0.150, 0.220 0.37 .712 1.94 0.00 0–68
  All symptoms, excl. risk of bias 
≥3
6 0.061 −0.139, 0.260 0.60 .550 0.97 0.00 0–75
  All symptoms, excl. risk of bias 
≥2
4 0.116 −0.119, 0.352 0.97 .333 0.09 0.00 0–85
  Positive symptoms, all eligible 
studies
5 −0.084 −0.315, 0.147 −0.71 .475 1.09 0.00 0–79
  Positive symptoms, risk of bias 
≥3
4 −0.078 −0.323, 0.166 −0.63 .530 1.06 0.00 0–85
  Negative symptoms, all eligible 
studies
7 0.001 −0.207, 0.209 0.03 .995 4.22 0.00 0–71
Table 3. Continued
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  Negative symptoms, excl. risk of 
bias ≥3
5 0.006 −0.223, 0.235 0.051 .958 2.28 0.00 0–79
  Social competency outcomes, all 
eligible studies
4 0.096 −0.186, 0.379 0.67 .503 0.62 0.00 0–85
SST vs any comparator; longest follow-up pooled
 All symptoms, all eligible studies 11 0.209* 0.043, 0.375 2.46 .014 7.65 0.00 0–60
  All symptoms, excl. risk of bias 
≥4
9 0.252* 0.075, 0.428 2.79 .005 5.17 0.00 0–65
  All symptoms, excl. risk of bias 
≥3
8 0.237* 0.056, 0.417 2.57 .010 4.54 0.00 0–68
  All symptoms, excl. risk of bias 
≥2
5 0.348 0.122, 0.574 3.02 .003 1.89 0.00 0–79
  Positive symptoms, all eligible 
studies
8 0.130 −0.152, 0.412 0.91 .366 16.34* 57.15 6–80
  Positive symptoms, risk of bias 
≥3
7 0.156 −0.150, 0.462 0.10 .318 15.66* 61.67 13–83
  Positive symptoms, risk of bias 
≥2
4 0.282 −0.196, 0.760 1.16 .247 11.57* 74.08 28–91
  Negative symptoms, all eligible 
studies
10 0.228* 0.025, 0.430 2.20 .028 12.51 28.70 0–65
  Negative symptoms, excl. risk of 
bias ≥3
8 0.267* 0.055, 0.478 2.47 .013 9.42 25.70 0–66
  Negative symptoms, excl. risk of 
bias ≥2
5 0.394* 0.148, 0.640 3.15 .002 4.66 14.19 0–82
  Social competency outcomes, all 
eligible studies
8 −0.100 −0.964, 0.765 −0.23 .821 112.22* 93.76 90–96
  Social competency outcomes, 
excl. bias ≥4
6 −0.221 −1.356, 0.914 −0.38 .703 111.59* 95.52 93–97
  Social competency outcomes, 
excl. bias ≥3
5 −0.331 −1.641, 0.978 0.50 .620 111.08* 96.40 94–98
  Social competency outcomes, 
excl. bias ≥2
4 −0.425 −2.165, 1.314 0.48 .632 111.08* 97.30 95–98
SST vs any comparator; all follow-up combined
 All symptoms, all eligible studies 11 0.141** −0.013, 0.294 1.79 .073 3.66 0.00 0–60
  All symptoms, excl. risk of bias 
≥4
10 0.169* 0.007, 0331 2.05 .041 1.93 0.00 0–62
  All symptoms, excl. risk of bias 
≥3
9 0.161** −0.004, 0.326 1.91 .057 1.71 0.00 0–65
  All symptoms, excl. risk of bias 
≥2
6 0.231* 0.033, 0.429 2.29 .022 0.09 0.00 0–75
  Positive symptoms, all eligible 
studies
8 0.045 −0.158, 0.247 0.43 .664 8.51 17.76 0–61
  Positive symptoms, risk of bias 
≥4
7 0.058 −0.165, 0.280 0.51 .612 8.24 27.17 0–68
  Positive symptoms, risk of bias 
≥2
4 0.130 −0.225, 0.484 0.72 .474 6.31 52.47 0–84
  Negative symptoms, all eligible 
studies
10 0.175** −0.025, 0.374 1.72 .086 12.02 25.12 0–64
  Negative symptoms, excl. risk of 
bias ≥4
8 0.204** −0.009, 0.416 1.88 .060 9.40 25.55 0–66
  Negative symptoms, excl. risk of 
bias ≥2
5 0.310* 0.052, 0.567 2.36 .018 5.02 20.35 0–66
  Social competency outcomes, all 
eligible studies
7 −0.224 −1.127, 0.679 0.47 .627 91.63* 93.45 89–96
  Social competency outcomes, 
excl. bias ≥4
5 −0.418 −1.659, 0.823 −0.66 .509 89.64* 95.54 92–97
  Social competency outcomes, 
excl. bias ≥2
4 −0.608 −2.107, 0.891 −0.80 .427 87.94* 96.59 94–98
Note: All comparisons were using random model. Risk of bias and subgroup analyses were only included in instances where at least four 
studies were available for that comparison. *P < .05. **P < .1. PANSS, Positive and Negative Syndromes Scale; CI, confidence Interval; 
SC, supportive counseling; UCLA-FAST, University of California Los Angeles-Functional Adaptive Skills Training.
Table 3. Continued
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the social performance domain displayed moderate-to-
high heterogeneity including significant effects.
Comparison of SST Subtypes
Table 3 provides results of  the comparison of  the a pri-
ori specified SST subtypes. The majority of  SST subtype 
comparisons were underpowered due to limited study 
availability. In order to assess trends in the data, effects 
that approached significance (P < .1) were noted and the 
magnitude of  nonsignificant effects was considered. The 
only subtype that demonstrated significant superiority 
was SCST, which demonstrated a relatively robust effect 
size at ≥3 (g = 0.39, P = .01) and ≥2 (g = 0.41, P = .01) 
bias levels against any comparator pooled for all symp-
tom measures pooled. Generic SST demonstrated an 
effect size that approached significance for all symp-
toms pooled (g = 0.36, P = .057), whereas for negative 
symptoms, a similar magnitude was observed despite 
the comparison being underpowered (g  =  0.27, P < 
.20). UCLA-FAST approaches showed a nonsignificant 
trend of  inferiority for all symptoms pooled vs any com-
parator, whereas CBSST comparisons were hampered 
by limited study availability. Comparisons of  CBSST 
showed no evidence of  heterogeneity, whereas generic 
SST and SCST symptom comparisons did not show 
significant heterogeneity. Heterogeneity was present for 
UCLA-FAST comparisons, although decreased as bias 
risk was reduced. Moderate-to-high heterogeneity was 
observed across social performance comparisons.
Follow-up
Limited RCT availability meant that meta-analyses on 
follow-up data were restricted to comparisons at 6-month 
follow-up, the longest available follow-up, and a pooled 
follow-up comparison in which an average effect size 
was calculated across follow-up measurements within 
each study. This section was restricted to all compara-
tors pooled rather than allowing TAU or active control 
comparisons. Comparisons were underpowered overall, 
whereas heterogeneity was consistently low.
SST did not show superiority over any comparator at 
6-month follow-up. At the longest available follow-up, 
SST demonstrated superiority for all symptoms when 
all eligible RCTs were included (g = 0.20, P = .01), at ≥4 
(g = 0.25, P = .01) and at ≥3 (g = 0.24, P = .01) risk of 
bias levels although lost significance at the most stringent 
≥2 risk of bias sensitivity analysis. For negative symp-
toms, SST demonstrated superiority in all comparisons at 
the longest available follow-up including when all eligible 
studies were included (g = 0.23, P = .01) and in the sensi-
tivity analyses for ≥3 (g = 0.27, P = .01) and ≥2 (g = 0.40, 
P = .002) risk of bias levels. When all follow-up measure-
ments were combined, SST demonstrated superiority for 
all symptoms at the ≥4 (g = 0.17, P = .04) risk of bias level 
and also the most stringent ≥2 level (g = 0.23, P = .02). 
For negative symptoms, the effect of SST approached sig-
nificance when all eligible studies were included and at 
the ≥4 risk of bias level. SST demonstrated superiority 
for negative symptoms at the most stringent sensitivity 
analysis for the ≥2 risk of bias level (g = 0.31, P = .02). 
Note. ALL, all comparators pooled; TAU, treatment-as-usual;  AC, active controls;  Social, social competency outcomes; 
General, PANSS general symptoms;  Negative, negative symptoms; Any, all eligible studies included;  <4, <3 and <2 denote 
sensitivity analyses progressively removing risk of bias.
vs TAU; all symptoms; any
vs TAU; all symptoms; <4
vs ALL; negative; any
vs ALL; negative; <4 
vs ALL; negative; <3
vs ALL; negative; <2
vs AC; negative; <3
vs AC; negative; <2
vs TAU; negative; any
vs TAU; negative; <4
vs ALL; general; any
vs TAU; general; any
vs ALL; social; any
vs ALL; social; <4
vs ALL; social; <3
-0.3 -0.1 0.1 0.3 0.5 0.7 0.9
g
Fig. 2. Summary forest plot of significant main results in Hedge’s g. ALL, all comparators pooled; TAU, treatment-as-usual; AC, active 
controls; Social, social competency outcomes; General, PANSS general symptoms; Negative, negative symptoms; Any, all eligible studies 
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This comparison was underpowered. Follow-up compar-
ison was not available for PANSS general symptoms due 
to limited study availability.
Publication Bias
Examination of funnel plots and consideration of the 
trim and fill procedure for effects that demonstrated sta-
tistical significance indicated the presence of publication 
bias in only one comparison. The funnel plot for SST vs 
all comparators pooled for general symptoms suggested 
that one study with negative findings had not been pub-
lished. The trim and fill procedure trimmed one study 
causing a marginal reduction in the magnitude of effect 
size in this comparison from g = 0.32 (P ≤ .05) to g = 0.26 
(95% CI 0.01, 0.53). The classic fail-safe N procedure sug-
gested that it would require seven missing studies to bring 
significance below the 0.05 alpha level, whereas Egger’s31 
test of the intercept did not demonstrate significance.
Discussion
The current meta-analysis provided a systematic and com-
prehensive overview of the efficacy of SST for psychosis 
while also investigating SST subtypes. SST demonstrated 
superiority for negative symptoms against all compara-
tors pooled, TAU, and active controls with small but 
reliable differences. SST did not demonstrate superiority 
over SC for negative symptoms, although this comparison 
was very low in power. SST also demonstrated superior-
ity against any comparator and TAU for PANSS general 
symptoms with small-to-medium effects. SST was supe-
rior to TAU when pooling all symptom measures but did 
not demonstrate superiority against comparators pooled, 
active control, or SC. There were no significant effects on 
positive symptoms. SST demonstrated superiority only 
against comparators pooled for social competency mea-
sures, although this effect lost significance as bias risk and 
power decreased. Significant effects for social outcomes 
were overall marginally larger than those for negative 
symptoms, although significant heterogeneity was pres-
ent across significant findings in this category while effects 
were not maintained against active controls. In SST sub-
type comparisons, only SCST demonstrated superiority 
to pooled comparators. Effects of SST vs all comparators 
for all symptoms pooled and negative symptoms were 
maintained on a proportion of follow-up comparisons.
As hypothesized, SST demonstrated superiority for 
negative symptoms including in comparison against 
active controls, which is the most stringent comparison 
category. SST also demonstrated beneficial effects on 
those comparisons possible for general symptoms. The 
overall trend in analyses for both negative and PANSS 
general symptoms showed that the magnitude of SST 
effect increased as risk of bias decreased, suggesting 
these effects may be robust. There was, however, still a 
minimal level of risk of bias present in the RCTs pooled 
to provide these conclusions because no RCT achieved 
the lowest possible risk of bias score. Sensitivity analy-
ses for social outcomes did not follow this trend, with 
the effect size decreasing and findings losing significant 
when bias was minimized. Similarly, many comparisons 
allowed only the least stringent category of sensitivity 
analysis due to limited availability of methodologically 
strong RCTs. Comparisons in the social performance 
domain displayed moderate-to-high heterogeneity. This 
heterogeneity may be a result of combining a high num-
ber of outcome measures that were not designed to mea-
sure a narrowly defined construct. Our combination of 
these measures may therefore indicate that a number of 
related but distinct outcomes were included, whereas a 
lack of robust significant effects in this domain may also 
be related to the heterogeneity in the included outcomes.
Although SCST demonstrated superiority to pooled 
comparators again with magnitude increasing as bias 
decreased, no other SST subtypes demonstrated supe-
riority in the context of low power across comparisons. 
There were two effects approaching significance: generic 
SST at ≥4 risk of bias sensitivity analysis and SCST at 
≥3 risk of bias sensitivity analysis, whereas UCLA-FAST 
performed poorly, despite having the highest statistical 
power. This may therefore suggest that “practical” life 
skills approaches have less beneficial impact upon symp-
toms than other subtypes. It is difficult to draw any con-
clusion regarding CBSST due to limited study availability. 
The identification of SST subtypes in meta-analysis may 
therefore become more relevant as the literature devel-
ops and future meta-analyses may benefit from increased 
study availability to bolster categories. Further research 
in this area, which can comprehensively compare the 
effectiveness of SST subtypes, may help influence the 
development of effective SST interventions.
The beneficial effects of SST were not evident at 
6-month follow-up, which was underpowered. Robust 
effects were however maintained for negative symptoms 
at the longest available follow-up point and in a less 
robust manner for all symptoms, whereas combining fol-
low-up points also demonstrated similar lasting effects of 
SST. SST has faced criticism that learning does not gener-
alize well to real-life situations.16 These findings indicate 
that SST has potential as an intervention that maintains 
effects outside the therapy group, although demonstrat-
ing generalizability and longevity remain important.
The effect sizes reported for SST for negative symptoms 
(g = 0.2–0.03) are marginally greater than those reported 
for CBT for positive symptoms and marginally smaller 
than those reported for antipsychotics,8,9 whereas current 
evidence does not support CBT for negative symptoms.14If  
we consider CBT as an intervention addressing positive 
symptoms and SST for negative symptoms, each inter-
vention has effects of roughly equivalent magnitude for 
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as a stand-alone intervention by NICE and therefore is 
not routinely implemented in the NHS.10 Furthermore, 
no UK RCTs met inclusion criteria for this meta-analysis, 
whereas many meet criteria for CBT meta-analyses.9,15,37,38 
It is possible that a culture toward cognitive-behavioral, 
formulation-based interventions is limiting the consider-
ation of alternative approaches that demonstrate similar 
efficacy. The group-based style of SST may lend itself  
well to application within a CMHT environment and has 
the potential to act as a cost-effective means of address-
ing negative symptoms, whereas improved care matching 
protocols may develop to help identify which patients 
may benefit most from the range of available interven-
tions and depending on their capacity to engage.39
The positive findings for SST on general psychopathol-
ogy are also of interest. The PANSS general psychopa-
thology subscale may be conceptualized as a measure of 
general distress including depression and anxiety, which 
have been identified as factorial dimensions within psy-
chosis symptomatology.40 Understanding of depression 
as an integral part of psychosis is limited as are targeted 
interventions. The small-to-medium effect sizes shown 
for SST in this domain suggest that targeting general psy-
chopathology is worthy of consideration for the broader 
recovery agenda41 while contemporary research challenges 
the traditionally prevalent assumption that psychosis 
and depression are aetiologically distinct.40 Considered 
broadly, these findings suggest the importance of devel-
oping interventions for psychosis populations that care-
fully consider the symptom and functioning domains 
measured by negative and general symptom scales.
It should also be recognized that negative symptoms 
represent heterogeneous sequelae within psychosis. 
Recent research supports a two-factor structure within 
negative symptoms in which expressive or neurocogni-
tive deficits are associated primarily with limited life 
functioning, whereas a second factor representing limited 
social motivation is associated with depressive symptom-
atology.41,42 Research on intervention targeting specific 
subgroups within negative symptoms is in its infancy.43 
Although simultaneously considering our findings on 
general symptoms, the potential crossover between nega-
tive symptoms and depressive symptomatology has impli-
cations for the development of effective interventions.
On a macro level, this review also provides support that 
small but reliable differences exist between psychological 
interventions, particularly on the outcomes targeted spe-
cifically by the intervention. This contradicts the Dodo 
verdict that all psychological interventions are equivalent 
because SST retained superiority for negative symptoms 
observed elsewhere.9,44 Small effect sizes and a number of 
nonsignificant comparisons vs active controls may also 
be interpreted as supportive of the premise that interven-
tions are roughly equivalent although the difficulty of 
low power in these comparisons should not be dismissed. 
Wampold45,46 highlights the tendency of meta-analyses 
of psychological interventions to establish targeted, 
symptom-specific improvement as opposed to improved 
general functioning. The observed effect on PANSS gen-
eral symptoms suggests that improvement may occur on 
outcomes capturing comorbidity, although our meth-
odology does not have the sophistication to specify the 
mechanism of such improvements.
There were a number of limitations including those 
inherent to meta-analyses and those specific to this 
review. With regard to the literature, although 27 RCTs 
were included, participant numbers in many trials were 
low.47 Many comparisons were therefore hampered by 
low power and there were not enough high quality stud-
ies minimizing bias risk to allow comparison at the lowest 
risk of bias level. This meant that any significant finding 
is still susceptible to some degree of potential bias.
Based on our comparison strategy, another limitation 
was that many RCTs had to be excluded due to the mixed 
nature of interventions; eg, integrating medication, exer-
cise, or other psychological therapies alongside SST. It 
was beyond the scope of this review to consider these 
interventions, although a narrative systematic review 
may help provide clarity on this burgeoning literature. 
Similarly, although we attempted to address the issue via 
joint decision-making, our categorization of SST sub-
types retains a degree of subjectivity while subtypes may 
contain heterogeneity. Nevertheless, the first meta-ana-
lytic consideration of SST subtypes provides guidance for 
future reviewers as this literature develops.
The lack of translation capability should also be con-
sidered a limitation in this review because we were unable 
to fully assess ten potential articles for inclusion. A final 
limitation is that a wider range of outcomes are rele-
vant to recovery from psychosis than those included in 
this review, eg, quality of life, neurocognitive function, 
relapse, or employment. Considering all such outcomes 
was beyond the scope of our project; therefore, depending 
on study availability, future research may consider them.
A further limitation of this review is that neither the meth-
odology nor the scope of this review allow insight into the 
mechanism of change by which SST modifies symptoms 
or social performance. In light of our findings, it is pos-
sible that SST exerts secondary change in negative symp-
toms via the primary target of social functioning, whereas 
an alternative possibility is that SST has direct impact 
upon negative symptoms such as poor rapport, emotional 
withdrawal, and passivity which in turn improves social 
performance. Moreover, there is considerable conceptual 
crossover among negative symptoms, general symptoms, 
and social functioning. Future research dismantling the 
mechanisms of SST is therefore warranted.
Taken in the context of wider research findings, the 
magnitude of effects demonstrated by SST for nega-
tive and general symptoms is relatively comparable to 
other interventions including the extent of benefit shown 
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aforementioned, we recognize that because the majority 
of participants in included RCTs would have been main-
tained on medication, the beneficial effects of SST are 
over and above any existing pharmacological effect on 
symptoms, whereas the efficacy of SST for unmedicated 
participants remains unknown.
The results of this meta-analysis suggest that SST has 
the potential for wider clinical application, whereas the 
level of evidence demonstrated for SST contradicts its 
exclusion by NICE in the UK.10 The effect sizes reported 
are impressive for a group-based psychological interven-
tion suggesting that SST may have potential as a cost-
effective alternative to individual therapies addressing 
negative and general symptoms in healthcare systems 
struggling to provide routine psychological intervention 
while SST may also provide a beneficial adjunct to CBTp 
focused on appraisal and positive symptoms.
Further high-quality outcome research may help 
clarify doubts regarding the applicability and durabil-
ity of SST in practice. At the very least, an RCT with 
stringent methodology applying SST for negative symp-
toms in a routine mental healthcare setting is warranted. 
Any future research may also benefit from integrating 
a cost-effectiveness analysis. Future SST research must 
focus upon further reducing risk of bias among RCTs 
and therefore allowing equivalence to CBT methodology 
alongside further addressing the concerns regarding gen-
eralizability and longevity. It is therefore important that 
methodologically stringent RCTs continue to integrate 
follow-up assessments on primary outcome measures, 
whereas the integration of booster sessions or any simi-
lar attempt to prolong beneficial effects, trouble-shoot, 
and increase applicability to real-life settings may help 
address pre-existing concerns. The significant findings on 
a proportion of follow-up comparisons suggest that fur-
ther development of SST is warranted.
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